Literature DB >> 7728994

Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes.

R D Minshall1, F Nakamura, R P Becker, S F Rabito.   

Abstract

Specific [125I-Tyr8]bradykinin (BK) binding was observed on myocardial membranes from adult guinea pigs, dogs, rats, and rabbits that was displaced by unlabeled BK with an IC50 between 0.1 and 30 nmol/L. In the adult guinea pig ventricular myocardium, which displays both high- and low-affinity binding, guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S; 100 mumol/L) eliminated high-affinity binding and reduced total specific [2,3-prolyl-3,4-3H(N)]BK ([3H]BK) binding by > 60%. Agonist competition binding to rat myocardial membranes was characterized as being of one affinity for BK in the nanomolar range, and it was not altered by GTP gamma S. Saturation binding studies with [125I-Tyr8]BK and [3H]BK, performed on cultured neonatal rat cardiac myocytes, revealed a single class of BK binding sites with a Kd and Bmax of 0.24 +/- 0.04 nmol/L and 18.4 +/- 1.1 fmol/mg protein, respectively (approximately 1500 receptors per cell). In competitive binding assays, unlabeled BK, Hoe 140 (a specific BK B2 receptor antagonist), and des-Arg9,[Leu8]BK (a BK B1 receptor antagonist) displaced [125I-Tyr8]BK with an IC50 of 4.3, 0.041, and 307 nmol/L, respectively. In the presence of 100 mumol/L GTP gamma S, [3H]BK binding to myocyte membranes was reduced by 40%, but the IC50 did not change. Cardiac fibroblasts, evaluated in parallel to the myocytes, contain a single class of [3H]BK binding sites (248 +/- 72 fmol/mg) with a 130-fold lower relative affinity (32.4 +/- 11.3 nmol/L) than that determined in rat cardiomyocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728994     DOI: 10.1161/01.res.76.5.773

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response.

Authors:  A Clerk; J Gillespie-Brown; S J Fuller; P H Sugden
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril.

Authors:  A Cargnoni; L Comini; P Bernocchi; T Bachetti; C Ceconi; S Curello; R Ferrari
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

4.  Agonist-induced localization of Gq-coupled receptors and G protein-gated inwardly rectifying K+ (GIRK) channels to caveolae determines receptor specificity of phosphatidylinositol 4,5-bisphosphate signaling.

Authors:  Shanyu Cui; Won-Kyung Ho; Seong-Tae Kim; Hana Cho
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 5.  Adenosine and bradykinin: are they independent triggers of preconditioning?

Authors:  T Miura
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

6.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Authors:  Y H Liu; X P Yang; V G Sharov; O Nass; H N Sabbah; E Peterson; O A Carretero
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

7.  Role of bradykinin in the antihypertrophic effects of enalapril in the newborn pig heart.

Authors:  C J Beinlich; C J Rissinger; K J Vitkauskas; H E Morgan
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

8.  Effect of angiotensin-converting enzyme inhibition on cardiovascular adaptation to exercise training.

Authors:  Tórur Sjúrðarson; Jacob Bejder; Andreas Breenfeldt Andersen; Thomas Bonne; Kasper Kyhl; Tóra Róin; Poula Patursson; Noomi Oddmarsdóttir Gregersen; May-Britt Skoradal; Michael Schliemann; Malte Lindegaard; Pál Weihe; Magni Mohr; Nikolai B Nordsborg
Journal:  Physiol Rep       Date:  2022-07

9.  Effects of a novel bradykinin B1 receptor antagonist and angiotensin II receptor blockade on experimental myocardial infarction in rats.

Authors:  Dongmei Wu; Xinchun Lin; Christian Bernloehr; Tobias Hildebrandt; Henri Doods
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

10.  High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

Authors:  Karin Tyralla; Marcin Adamczak; Kerstin Benz; Valentina Campean; Marie-Luise Gross; Karl F Hilgers; Eberhard Ritz; Kerstin Amann
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.